Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion, and public health priorities in his first ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Hawaiʻi lawmakers are considering regulating kratom and banning sales to minors. But kava advocates want an outright ban.

The chicken before me had neither lived nor died, but it did look really tasty. Five stories up, in a sunny event space tucked away in New York City’s Little Italy earlier this month, chefs had been ...

Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...

During his confirmation hearing before the Senate Finance Committee on Wednesday, Robert F. Kennedy Jr. tackled a topic of ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...

"Walking back REMS has significantly increased safety risks for women. And so from our perspective, as directed by the ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

FDA faces radical changes under Trump, risking public health and regulatory stability. • Trump reinstates the “Schedule F” order, threatening federal employees’ job security and increasing political ...